1. Home
  2. MNKD vs TPB Comparison

MNKD vs TPB Comparison

Compare MNKD & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • TPB
  • Stock Information
  • Founded
  • MNKD 1991
  • TPB 1988
  • Country
  • MNKD United States
  • TPB United States
  • Employees
  • MNKD N/A
  • TPB N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • TPB Tobacco
  • Sector
  • MNKD Health Care
  • TPB Consumer Discretionary
  • Exchange
  • MNKD Nasdaq
  • TPB Nasdaq
  • Market Cap
  • MNKD 1.4B
  • TPB 1.3B
  • IPO Year
  • MNKD 2004
  • TPB 2016
  • Fundamental
  • Price
  • MNKD $3.55
  • TPB $72.69
  • Analyst Decision
  • MNKD Buy
  • TPB Strong Buy
  • Analyst Count
  • MNKD 4
  • TPB 4
  • Target Price
  • MNKD $9.75
  • TPB $73.75
  • AVG Volume (30 Days)
  • MNKD 3.4M
  • TPB 284.9K
  • Earning Date
  • MNKD 08-06-2025
  • TPB 07-31-2025
  • Dividend Yield
  • MNKD N/A
  • TPB 0.41%
  • EPS Growth
  • MNKD 228.27
  • TPB N/A
  • EPS
  • MNKD 0.10
  • TPB N/A
  • Revenue
  • MNKD $297,595,000.00
  • TPB $384,032,000.00
  • Revenue This Year
  • MNKD $13.72
  • TPB $21.66
  • Revenue Next Year
  • MNKD $15.21
  • TPB $9.08
  • P/E Ratio
  • MNKD $34.56
  • TPB N/A
  • Revenue Growth
  • MNKD 32.50
  • TPB 24.54
  • 52 Week Low
  • MNKD $3.56
  • TPB $31.97
  • 52 Week High
  • MNKD $7.63
  • TPB $81.25
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 35.30
  • TPB 46.97
  • Support Level
  • MNKD $3.65
  • TPB $72.30
  • Resistance Level
  • MNKD $4.00
  • TPB $76.54
  • Average True Range (ATR)
  • MNKD 0.15
  • TPB 2.90
  • MACD
  • MNKD 0.00
  • TPB -0.43
  • Stochastic Oscillator
  • MNKD 12.16
  • TPB 5.10

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About TPB Turning Point Brands Inc.

Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.

Share on Social Networks: